NovaBay Pharmaceuticals, Inc. (NBY)
USD 0.49
(-9.24%)
USD 0.49
(-9.24%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 14.72 Million | 14.4 Million | 8.42 Million | 9.93 Million | 6.59 Million | 12.5 Million |
| Cost of Revenue | 6.83 Million | 6.62 Million | 2.77 Million | 3.97 Million | 1.73 Million | 1.5 Million |
| Gross Profit | 7.89 Million | 7.78 Million | 5.64 Million | 5.96 Million | 4.86 Million | 11 Million |
| Operating Expenses | 12.89 Million | 15.46 Million | 14.5 Million | 12.39 Million | 14.26 Million | 18.87 Million |
| Selling, General and Administrative Expenses | 12.83 Million | 15.28 Million | 14.46 Million | 12.1 Million | 14.07 Million | 18.61 Million |
| Research and Development Expenses | 68 Thousand | 174 Thousand | 44 Thousand | 285 Thousand | 184 Thousand | 259 Thousand |
| Other Expenses | - | -276 Thousand | -1.57 Million | 605 Thousand | -1.42 Million | 19 Thousand |
| Cost and Expenses | 19.72 Million | 22.08 Million | 17.28 Million | 16.36 Million | 15.99 Million | 20.37 Million |
| Operating Income | -5 Million | -7.68 Million | -8.86 Million | -6.42 Million | -9.4 Million | -7.87 Million |
| Interest Expense | - | - | - | - | 1.05 Million | - |
| Income Tax Expense | - | -3.8 Million | -4.61 Million | 5000.00 | 6000.00 | 4000.00 |
| Earnings before Tax | -9.64 Million | -10.6 Million | -5.82 Million | -11.03 Million | -9.65 Million | -6.54 Million |
| Net Income | -9.64 Million | -16.26 Million | -6.55 Million | -11.03 Million | -10.48 Million | -6.54 Million |
| Earnings Per Share Basic | -138.65 | -353.59 | -184.09 | -385.53 | -593.63 | -473.83 |
| Earnings Per Share Diluted | -138.65 | -353.59 | -184.09 | -385.53 | -593.63 | -564.17 |
| Weighted Average Shares Outstanding | 120.42 Thousand | 30 Thousand | 31.63 Thousand | 28.63 Thousand | 16.26 Thousand | 11.6 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 120.42 Thousand | 46 Thousand | 35.62 Thousand | 28.63 Thousand | 17.66 Thousand | 13.92 Thousand |
| Gross Margin | 0.54 | 0.54 | 0.67 | 0.60 | 0.74 | 0.88 |
| EBIT Margin | -0.33 | -0.32 | -1.59 | -0.12 | -1.59 | -0.71 |
| Profit Margin | -0.65 | -1.13 | -0.78 | -1.11 | -1.59 | -0.52 |
| EBITDA | -4.8 Million | -7.19 Million | -8.74 Million | -6.37 Million | -9.33 Million | -7.6 Million |
| Earnings Before Tax Margin | -0.34 | -0.53 | -1.05 | -0.65 | -1.42 | -0.63 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 2.4 Million | 2.63 Million | 3.72 Million | 14.72 Million | 3.25 Million | 4.61 Million |
| Cost of Revenue | 808 Thousand | 837 Thousand | 1.91 Million | 6.83 Million | 1.41 Million | 2.3 Million |
| Gross Profit | 1.59 Million | 1.79 Million | 1.81 Million | 7.89 Million | 1.83 Million | 2.3 Million |
| Operating Expenses | 2.64 Million | 3.36 Million | 2.61 Million | 12.89 Million | 2.95 Million | 3.66 Million |
| Selling, General and Administrative Expenses | 2.63 Million | 3.34 Million | 2.6 Million | - | 2.94 Million | 3.63 Million |
| Research and Development Expenses | 9000.00 | 19 Thousand | 4000.00 | - | 11 Thousand | 27 Thousand |
| Other Expenses | -69 Thousand | -480 Thousand | -766 Thousand | -2.06 Million | -641 Thousand | -937 Thousand |
| Cost and Expenses | 3.45 Million | 4.2 Million | 4.52 Million | 19.72 Million | 4.37 Million | 5.96 Million |
| Operating Income | -1.05 Million | -1.57 Million | -798 Thousand | -5 Million | -1.11 Million | -1.35 Million |
| Interest Expense | 300 Thousand | 433 Thousand | -5000.00 | - | - | 501 Thousand |
| Income Tax Expense | - | 124 Thousand | 302 Thousand | 35.1 Thousand | -51 Thousand | -256 Thousand |
| Earnings before Tax | -1.58 Million | -3.09 Million | -4.1 Million | -9.64 Million | -1.75 Million | -2.03 Million |
| Net Income | -1.58 Million | -3.21 Million | -4.1 Million | -9.64 Million | -1.75 Million | -4.03 Million |
| Earnings Per Share Basic | -1.37 | -0.13 | -0.37 | - | -0.37 | -1.27 |
| Earnings Per Share Diluted | -1.37 | -0.13 | -0.37 | - | -0.37 | -1.27 |
| Weighted Average Shares Outstanding | 1.15 Million | 24.67 Million | 11.23 Million | 4.21 Million | 4.69 Million | 3.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.15 Million | 24.67 Million | 11.23 Million | 4.21 Million | 4.69 Million | 3.17 Million |
| Gross Margin | 0.66 | 0.68 | 0.49 | 0.54 | 0.56 | 0.50 |
| EBIT Margin | -0.43 | -0.59 | -0.20 | - | -0.34 | -0.34 |
| Profit Margin | -0.66 | -1.22 | -1.10 | -0.65 | -0.54 | -0.87 |
| EBITDA | -1.04 Million | -1.55 Million | -748 Thousand | - | -1.11 Million | -1.56 Million |
| Earnings Before Tax Margin | -0.44 | -0.60 | -0.21 | -0.34 | -0.34 | -0.29 |
SNWV
5238
6550
AKMYF
ACWRF
7214